XM does not provide services to residents of the United States of America.

South Korean shares end lower; post best week in 1-1/2 months



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>South Korean shares end lower; post best week in 1-1/2 months</title></head><body>

KOSPI falls, foreigners net buyers

Korean won little changed against dollar

South Korea benchmark bond yield steady

For the midday report, please click nL1N3L902C

SEOUL, Sept 27 (Reuters) -Round-up of South Korean financial markets:


** South Korean shares fell on Friday, led by losses in biopharmaceutical stocks, but posted their biggest weekly gains in six.

** The benchmark KOSPI .KS11 closed down 21.79 points, or 0.82%, at 2,649.78. The index had jumped 2.9% in the previous session.

** For the week, the KOSPI advanced2.2%, its third straight week of gains, and loggedits best week since mid-August.

** "Despite positive external conditions from China's stimulus policies and U.S. rate cuts, the domestic market saw investors taking profits from the previous session's sharp gains," said Seo Sang-young, an analyst at Mirae Asset Securities.

** South Korea's exports are expected to have risen for a 12th straight month in September but the pace slowed to a three-month low, according to a Reuters poll.

** Biopharmaceutical stocks slumped 4.6% on the day, with Samsung Biologics 207940.KS and Celltrion 068270.KSS falling 6.27% and 3.56%, respectively.

** Chipmaker SK Hynix 000660.KS advanced1.60%, tracking the Philadelphia Semiconductor Index's .SOX sharp gains in the previous session, but rival Samsung Electronics 005930.KS fell 0.77%.

** Other index heavyweights, such asautomakers and e-commerce firms, fell on Friday.

** Oil refiner S-Oil 010950.KS fell 1.77% after itshut down some of itsrefining units.

** Of the total 936 traded issues, 417 shares advanced, while 459 declined.

** Foreigners were net buyers of shares worth 262 billion won ($198.8 million).

** The won was quoted at 1,318.6 per dollar on the onshore settlement platform KRW=KFTC, 0.05% lower than its previous close at 1,318.0.

** In money and debt markets, December futures on three-year treasury bonds KTBc1 fell 0.04 point to 106.33.

** The most liquid three-year Korean treasury bond yield rose by 1.3 basis points to 2.826%, while the benchmark 10-year yield rose by 0.3 bpto 3.002%.


($1 = 1,317.7900 won)



Reporting by Jihoon Lee; Editing by Sonia Cheema

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.